DrugPatentWatch Database Preview
Drugs in Development Information for N,N-Dimethyltryptamine
What is the drug development status for N,N-Dimethyltryptamine?
N,N-Dimethyltryptamine is an investigational drug.
There have been 5 clinical trials for N,N-Dimethyltryptamine.
The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2009.
The most common disease conditions in clinical trials are Tobacco Use Disorder, Depression, and [disabled in preview]. The leading clinical trial sponsors are Heffter Research Institute, Johns Hopkins University, and New York University.
Summary for N,N-Dimethyltryptamine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 206 |
| WIPO Patent Applications | 154 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2009-02-01) |
| Vendors | 26 |
Recent Clinical Trials for N,N-Dimethyltryptamine
| Title | Sponsor | Phase |
|---|---|---|
| Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors | Heffter Research Institute | Phase 1 |
| Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors | River Styx Foundation | Phase 1 |
| Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors | Stupski Foundation | Phase 1 |
Clinical Trial Summary for N,N-Dimethyltryptamine
Top disease conditions for N,N-Dimethyltryptamine
Top clinical trial sponsors for N,N-Dimethyltryptamine
US Patents for N,N-Dimethyltryptamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
